Home
About Nanexa
Pharmashell®
Projects
Investors
Media
Contact
English
- Swedish

Home
About Nanexa
- Company
- Management
- Board
- Our story
Pharmashell®
Projects
Investors
Media
Contact

English
Svenska

Allt inom stammor

Annual General Meeting 2026

Annual General Meeting 2026, 12th of May 2026

Annual General Meeting 2025

Annual General Meeting 2025, 15th of May 2025

Nanexa is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell® – the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. Nanexa develops its own products and also has collaboration agreements with several pharma companies, among others Moderna.

CONTACT

Nanexa AB, Virdings Allé 2, SE-75450 Uppsala, Sweden
Phone: +46 (0) 18 100 300
E-mail: info@nanexa.se
Org nr. 556833-0285

Integritetspolicy
Integritetspolicy för aktieägare

English
Svenska